Keywords: Czech Republic, Pharmaceutical market, BMI, Drug pricing, Reimbursement, Elections

Drug pricing and reimbursement remain concerns for Czech pharmaceuticals, says BMI

Article | 13 September 2010

As far as its pharmaceutical market in concerned, the Czech Republic retained its pole position, which it climbed to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in